This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Choroidal Neovascularization  • Retinal/ Chorioretinal Disorders  • Alert me on articles by topic

Arch Ophthalmol. 2006;124:741-743.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Choroidal neovascularization (CNV) can arise secondary to the retinochoroiditis and macular scarring from ocular toxoplasmosis.^1-2 Treatment of CNV due to toxoplasmosis can include corticosteroids, cryotherapy, laser photocoagulation, submacular surgery, and verteporfin photodynamic therapy (PDT).^1-4 We describe 2 cases of CNV secondary to toxoplasmosis treated successfully with PDT.

Report of Cases

Case 1. A 20-year-old man with a diagnosis of congenital ocular toxoplasmosis with bilateral macular scars sought care because of a 9-month history of decreasing vision and metamorphopsia in the right eye. Visual acuity was 1/200 OD. Fundus examination results revealed a subfoveal chorioretinal scar with surrounding subretinal hemorrhage and exudate (Figure 1A). Fluorescein angiographic images identified central leakage from the CNV with surrounding blocked fluorescence corresponding to the hemorrhage (Figure 1B and C), while indocyanine green angiographic images were able to provide visualization through the hemorrhage. The eye was treated with PDT and the greatest linear dimension . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION
Robert Wirthlin, MD; Alice Song, MD; Julia Song, MD; Philip J. Rosenfeld, MD, PhD